![Phylogenetic Tree of Bacteria Implicated in Response and Toxicity with Immunotherapy Phylogenetic Tree of Bacteria Implicated in Response and Toxicity with Immunotherapy](/content/dam/taconic/legacy/about-us/news/images/phylogenetic-tree-bacteria-implicated-response-toxicity-immunotherapy.png)
"Researchers' understanding of why patients with cancer do or do not respond to treatment with immune checkpoint inhibition is constantly evolving, with new developments in innate and adaptive immunity, the tumor microenvironment, and more changing the way that immunotherapy is viewed and used. Many researchers are now pointing to the effect that gut microbiota have on patients' response to checkpoint inhibitors and its implications for the treatment of patients receiving immunotherapy.
The first major papers to show that gut microbiota may help determine which patients with cancer respond to checkpoint blockades appeared in Science 3 years ago."
Read* the complete article at: Targetedonc.com
The first major papers to show that gut microbiota may help determine which patients with cancer respond to checkpoint blockades appeared in Science 3 years ago."